Use of anthracyclines and trastuzumab for breast cancer in women with and without a history of cardiovascular disease in Sweden: a national cross-sectional study

Use of anthracyclines and trastuzumab for breast cancer in women with and without a history of cardiovascular disease in Sweden: a national cross-sectional study

Abstract Background Cardiovascular toxicity concerns have limited the use of anthracyclines and trastuzumab among breast cancer patients with cardiovascular disease (CVD) but evidence on real-world prescribing patterns is scarce. We aimed to describe the use of these drugs in women with and without...

Full description

Saved in:
Bibliographic Details
Main Authors: Helena Carreira, Helen Strongman, Maria Feychting, Laila Hubbert, Elham Hedayati, Patrick Bidulka, Anthony Matthews, Krishnan Bhaskaran
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Cardio-Oncology
Online Access:https://doi.org/10.1186/s40959-025-00356-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items